Sun Pharma Acquires Concert Pharmaceuticals to Broaden its Dermatology Portfolio
By Ayush Saxena
Pharma Deals Review: Vol 2023 Issue 2 (Table of Contents)
Published: 1 Feb-2023
DOI: 10.3833/pdr.v2023.i2.2760 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to expand its dermatology portfolio, Sun Pharma has agreed to buy Concert Pharmaceuticals under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of US$8 per share of common stock in cash or US$576 M in equity value...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS